{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T16:26:40Z","timestamp":1747412800310},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,2,17]],"date-time":"2011-02-17T00:00:00Z","timestamp":1297900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,2,17]],"date-time":"2011-02-17T00:00:00Z","timestamp":1297900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s00296-011-1830-1","type":"journal-article","created":{"date-parts":[[2011,2,16]],"date-time":"2011-02-16T20:03:50Z","timestamp":1297886630000},"page":"1581-1587","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Decreased levels of sCD21 and sCD23 in blood of patients with systemic-juvenile arthritis, polyarticular-juvenile arthritis, and pauciarticular-juvenile arthritis"],"prefix":"10.1007","volume":"32","author":[{"given":"Anjana","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastiaan J.","family":"Vastert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berent J.","family":"Prakken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"Illges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,2,17]]},"reference":[{"issue":"2","key":"1830_CR1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0950-3579(98)80014-9","volume":"12","author":"BA Gare","year":"1998","unstructured":"Gare BA (1998) Epidemiology. Baillieres Clin Rheumatol 12(2):191\u2013208","journal-title":"Baillieres Clin Rheumatol"},{"issue":"2","key":"1830_CR2","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S0889-857X(05)70204-0","volume":"27","author":"GS Panayi","year":"2001","unstructured":"Panayi GS, Corrigall VM, Pitzalis C (2001) Pathogenesis of rheumatoid arthritis. The role of T cells and other beasts. Rheum Dis Clin North Am 27(2):317\u2013334","journal-title":"Rheum Dis Clin North Am"},{"issue":"2","key":"1830_CR3","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1046\/j.1365-2567.1999.00772.x","volume":"97","author":"JC Edwards","year":"1999","unstructured":"Edwards JC, Cambridge G, Abrahams VM (1999) Do self-perpetuating B lymphocytes drive human autoimmune disease? Immunology 97(2):188\u2013196","journal-title":"Immunology"},{"issue":"2","key":"1830_CR4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/rheumatology\/40.2.205","volume":"40","author":"JC Edwards","year":"2001","unstructured":"Edwards JC, Cambridge G (2001) Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes. Rheumatology (Oxford) 40(2):205\u2013211","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"1830_CR5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/rheumatology\/39.2.189","volume":"39","author":"A Aggarwal","year":"2000","unstructured":"Aggarwal A, Bhardwaj A, Alam S, Misra R (2000) Evidence for activation of the alternate complement pathway in patients with juvenile rheumatoid arthritis. Rheumatology (Oxford) 39(2):189\u2013192","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"1830_CR6","first-page":"53","volume":"4","author":"JJ Miller 3rd","year":"1986","unstructured":"Miller JJ 3rd, Olds LC, Huene DB (1986) Complement activation products and factors influencing phagocyte migration in synovial fluids from children with chronic arthritis. Clin Exp Rheumatol 4(1):53\u201356","journal-title":"Clin Exp Rheumatol"},{"key":"1830_CR7","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0065-2776(08)60654-9","volume":"46","author":"JM Ahearn","year":"1989","unstructured":"Ahearn JM, Fearon DT (1989) Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21). Adv Immunol 46:183\u2013219","journal-title":"Adv Immunol"},{"issue":"2","key":"1830_CR8","doi-asserted-by":"crossref","first-page":"678","DOI":"10.4049\/jimmunol.133.2.678","volume":"133","author":"TF Tedder","year":"1984","unstructured":"Tedder TF, Clement LT, Cooper MD (1984) Expression of C3d receptors during human B cell differentiation: immunofluorescence analysis with the HB-5 monoclonal antibody. J Immunol 133(2):678\u2013683","journal-title":"J Immunol"},{"issue":"4","key":"1830_CR9","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.4049\/jimmunol.135.4.2687","volume":"135","author":"M Reynes","year":"1985","unstructured":"Reynes M, Aubert JP, Cohen JH, Audouin J, Tricottet V, Diebold J, Kazatchkine MD (1985) Human follicular dendritic cells express CR1, CR2, and CR3 complement receptor antigens. J Immunol 135(4):2687\u20132694","journal-title":"J Immunol"},{"issue":"3","key":"1830_CR10","doi-asserted-by":"crossref","first-page":"865","DOI":"10.4049\/jimmunol.146.3.865","volume":"146","author":"E Fischer","year":"1991","unstructured":"Fischer E, Delibrias C, Kazatchkine MD (1991) Expression of CR2 (the C3dg\/EBV receptor, CD21) on normal human peripheral blood T lymphocytes. J Immunol 146(3):865\u2013869","journal-title":"J Immunol"},{"issue":"2","key":"1830_CR11","first-page":"103","volume":"3","author":"C Larcher","year":"1990","unstructured":"Larcher C, Schulz TF, Hofbauer J, Hengster P, Romani N, Wachter H, Dierich MP (1990) Expression of the C3d\/EBV receptor and of other cell membrane surface markers is altered upon HIV-1 infection of myeloid, T, and B cells. J Acquir Immune Defic Syndr 3(2):103\u2013108","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"1830_CR12","doi-asserted-by":"crossref","first-page":"768","DOI":"10.4049\/jimmunol.149.3.768","volume":"149","author":"CC Delibrias","year":"1992","unstructured":"Delibrias CC, Fischer E, Bismuth G, Kazatchkine MD (1992) Expression, molecular association, and functions of C3 complement receptors CR1 (CD35) and CR2 (CD21) on the human T cell line HPB-ALL. J Immunol 149(3):768\u2013774","journal-title":"J Immunol"},{"issue":"1","key":"1830_CR13","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S0952-7915(98)80028-9","volume":"10","author":"MC Carroll","year":"1998","unstructured":"Carroll MC, Prodeus AP (1998) Linkages of innate and adaptive immunity. Curr Opin Immunol 10(1):36\u201340","journal-title":"Curr Opin Immunol"},{"key":"1830_CR14","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1146\/annurev.immunol.18.1.393","volume":"18","author":"DT Fearon","year":"2000","unstructured":"Fearon DT, Carroll MC (2000) Regulation of B lymphocyte responses to foreign and self-antigens by the CD19\/CD21 complex. Annu Rev Immunol 18:393\u2013422","journal-title":"Annu Rev Immunol"},{"issue":"9","key":"1830_CR15","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1002\/eji.200323843","volume":"33","author":"M Masilamani","year":"2003","unstructured":"Masilamani M, Kassahn D, Mikkat S, Glocker MO, Illges H (2003) B cell activation leads to shedding of complement receptor type II (CR2\/CD21). Eur J Immunol 33(9):2391\u20132397","journal-title":"Eur J Immunol"},{"issue":"2","key":"1830_CR16","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1365-2249.1993.tb07965.x","volume":"93","author":"HP Huemer","year":"1993","unstructured":"Huemer HP, Larcher C, Prodinger WM, Petzer AL, Mitterer M, Falser N (1993) Determination of soluble CD21 as a parameter of B cell activation. Clin Exp Immunol 93(2):195\u2013199","journal-title":"Clin Exp Immunol"},{"key":"1830_CR17","doi-asserted-by":"crossref","unstructured":"Singh A, Blank M, Shoenfeld Y, Illges H (2008) Antiphospholipid syndrome patients display reduced titers of soluble CD21 in their sera irrespective of circulating anti-beta2-glycoprotein-I autoantibodies. Rheumatol Int","DOI":"10.1007\/978-3-7908-2127-7_30"},{"issue":"2","key":"1830_CR18","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1093\/rheumatology\/keg449","volume":"43","author":"M Masilamani","year":"2004","unstructured":"Masilamani M, von Kempis J, Illges H (2004) Decreased levels of serum soluble complement receptor-II (CR2\/CD21) in patients with rheumatoid arthritis. Rheumatology (Oxford) 43(2):186\u2013190","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"1830_CR19","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1046\/j.1365-2249.2000.01379.x","volume":"122","author":"H Illges","year":"2000","unstructured":"Illges H, Braun M, Peter HH, Melchers I (2000) Reduced expression of the complement receptor type 2 (CR2, CD21) by synovial fluid B and T lymphocytes. Clin Exp Immunol 122(2):270\u2013276","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"1830_CR20","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/j.0300-9475.2004.01494.x","volume":"60","author":"M Masilamani","year":"2004","unstructured":"Masilamani M, Nowack R, Witte T, Schlesier M, Warnatz K, Glocker MO, Peter HH, Illges H (2004) Reduction of soluble complement receptor 2\/CD21 in systemic lupus erythomatosus and Sjoegren\u2019s syndrome but not juvenile arthritis. Scand J Immunol 60(6):625\u2013630","journal-title":"Scand J Immunol"},{"issue":"12","key":"1830_CR21","doi-asserted-by":"publisher","first-page":"4268","DOI":"10.1002\/(SICI)1521-4141(199812)28:12<4268::AID-IMMU4268>3.0.CO;2-9","volume":"28","author":"V Fremeaux-Bacchi","year":"1998","unstructured":"Fremeaux-Bacchi V, Aubry JP, Bonnefoy JY, Kazatchkine MD, Kolb JP, Fischer EM (1998) Soluble CD21 induces activation and differentiation of human monocytes through binding to membrane CD23. Eur J Immunol 28(12):4268\u20134274","journal-title":"Eur J Immunol"},{"key":"1830_CR22","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0065-2776(08)60776-2","volume":"49","author":"G Delespesse","year":"1991","unstructured":"Delespesse G, Suter U, Mossalayi D, Bettler B, Sarfati M, Hofstetter H, Kilcherr E, Debre P, Dalloul A (1991) Expression, structure, and function of the CD23 antigen. Adv Immunol 49:149\u2013191","journal-title":"Adv Immunol"},{"key":"1830_CR23","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1600-065X.1992.tb00626.x","volume":"125","author":"G Delespesse","year":"1992","unstructured":"Delespesse G, Sarfati M, Wu CY, Fournier S, Letellier M (1992) The low-affinity receptor for IgE. Immunol Rev 125:77\u201397","journal-title":"Immunol Rev"},{"issue":"3\u20134","key":"1830_CR24","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/BF02919132","volume":"11","author":"M Sarfati","year":"1992","unstructured":"Sarfati M, Fournier S, Wu CY, Delespesse G (1992) Expression, regulation and function of human Fc epsilon RII (CD23) antigen. Immunol Res 11(3\u20134):260\u2013272","journal-title":"Immunol Res"},{"issue":"5","key":"1830_CR25","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1002\/eji.1830210504","volume":"21","author":"YJ Liu","year":"1991","unstructured":"Liu YJ, Cairns JA, Holder MJ, Abbot SD, Jansen KU, Bonnefoy JY, Gordon J, MacLennan IC (1991) Recombinant 25-kDa CD23 and interleukin 1 alpha promote the survival of germinal center B cells: evidence for bifurcation in the development of centrocytes rescued from apoptosis. Eur J Immunol 21(5):1107\u20131114","journal-title":"Eur J Immunol"},{"issue":"1","key":"1830_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0022-1759(02)00211-9","volume":"270","author":"M Masilamani","year":"2002","unstructured":"Masilamani M, Apell HJ, Illges H (2002) Purification and characterization of soluble CD21 from human plasma by affinity chromatography and density gradient centrifugation. J Immunol Methods 270(1):11\u201318","journal-title":"J Immunol Methods"},{"issue":"2","key":"1830_CR27","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/BF02505047","volume":"288","author":"S Sato","year":"1996","unstructured":"Sato S, Fujimoto M, Kikuchi K, Ihn H, Tamaki K, Takehara K (1996) Elevated soluble CD23 levels in the sera from patients with localized scleroderma. Arch Dermatol Res 288(2):74\u201378","journal-title":"Arch Dermatol Res"},{"issue":"3","key":"1830_CR28","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/j.1365-2249.1992.tb06979.x","volume":"89","author":"A Bansal","year":"1992","unstructured":"Bansal A, Roberts T, Hay EM, Kay R, Pumphrey RS, Wilson PB (1992) Soluble CD23 levels are elevated in the serum of patients with primary Sjoegren\u2019s syndrome and systemic lupus erythematosus. Clin Exp Immunol 89(3):452\u2013455","journal-title":"Clin Exp Immunol"},{"issue":"8","key":"1830_CR29","doi-asserted-by":"crossref","first-page":"5379","DOI":"10.4049\/jimmunol.175.8.5379","volume":"175","author":"CJ Del Nagro","year":"2005","unstructured":"Del Nagro CJ, Kolla RV, Rickert RC (2005) A critical role for complement C3d and the B cell coreceptor (CD19\/CD21) complex in the initiation of inflammatory arthritis. J Immunol 175(8):5379\u20135389","journal-title":"J Immunol"},{"issue":"3","key":"1830_CR30","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/0952-7915(95)80110-3","volume":"7","author":"JY Bonnefoy","year":"1995","unstructured":"Bonnefoy JY, Lecoanet-Henchoz S, Aubry JP, Gauchat JF, Graber P (1995) CD23 and B-cell activation. Curr Opin Immunol 7(3):355\u2013359","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"1830_CR31","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4049\/jimmunol.167.1.163","volume":"167","author":"A Cherukuri","year":"2001","unstructured":"Cherukuri A, Cheng PC, Pierce SK (2001) The role of the CD19\/CD21 complex in B cell processing and presentation of complement-tagged antigens. J Immunol 167(1):163\u2013172","journal-title":"J Immunol"},{"issue":"8","key":"1830_CR32","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1002\/eji.1830230806","volume":"23","author":"P Bjorck","year":"1993","unstructured":"Bjorck P, Elenstrom-Magnusson C, Rosen A, Severinson E, Paulie S (1993) CD23 and CD21 function as adhesion molecules in homotypic aggregation of human B lymphocytes. Eur J Immunol 23(8):1771\u20131775. doi:10.1002\/eji.1830230806","journal-title":"Eur J Immunol"},{"issue":"15","key":"1830_CR33","doi-asserted-by":"publisher","first-page":"6835","DOI":"10.1073\/pnas.91.15.6835","volume":"91","author":"H Fujiwara","year":"1994","unstructured":"Fujiwara H, Kikutani H, Suematsu S, Naka T, Yoshida K, Tanaka T, Suemura M, Matsumoto N, Kojima S et al (1994) The absence of IgE antibody-mediated augmentation of immune responses in CD23-deficient mice. Proc Natl Acad Sci U S A 91(15):6835\u20136839","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1830_CR34","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/eji.1830270232","volume":"27","author":"R Reljic","year":"1997","unstructured":"Reljic R, Cosentino G, Gould HJ (1997) Function of CD23 in the response of human B cells to antigen. Eur J Immunol 27(2):572\u2013575. doi:10.1002\/eji.1830270232","journal-title":"Eur J Immunol"},{"issue":"1","key":"1830_CR35","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/1074-7613(95)90164-7","volume":"3","author":"S Lecoanet-Henchoz","year":"1995","unstructured":"Lecoanet-Henchoz S, Gauchat JF, Aubry JP, Graber P, Life P, Paul-Eugene N, Ferrua B, Corbi AL, Dugas B, Plater-Zyberk C et al (1995) CD23 regulates monocyte activation through a novel interaction with the adhesion molecules CD11b-CD18 and CD11c-CD18. Immunity 3(1):119\u2013125","journal-title":"Immunity"},{"issue":"2","key":"1830_CR36","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0092-8674(87)90216-9","volume":"50","author":"J Tanner","year":"1987","unstructured":"Tanner J, Weis J, Fearon D, Whang Y, Kieff E (1987) Epstein-Barr virus gp350\/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis. Cell 50(2):203\u2013213. doi:0092-8674(87)90216-9","journal-title":"Cell"},{"issue":"3","key":"1830_CR37","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1073\/pnas.81.3.881","volume":"81","author":"JJ Weis","year":"1984","unstructured":"Weis JJ, Tedder TF, Fearon DT (1984) Identification of a 145, 000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes. Proc Natl Acad Sci U S A 81(3):881\u2013885","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1830_CR38","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1136\/ard.61.2.167","volume":"61","author":"CY Chen","year":"2002","unstructured":"Chen CY, Tsao CH, Ou LS, Yang MH, Kuo ML, Huang JL (2002) Comparison of soluble adhesion molecules in juvenile idiopathic arthritis between the active and remission stages. Ann Rheum Dis 61(2):167\u2013170","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-011-1830-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-011-1830-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-011-1830-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-011-1830-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T07:13:45Z","timestamp":1685949225000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-011-1830-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,17]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["1830"],"URL":"https:\/\/doi.org\/10.1007\/s00296-011-1830-1","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,17]]},"assertion":[{"value":"20 October 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}